Fumiyoshi Yamashita

Fumiyoshi Yamashita

Auto-generated profile, based on publicly available information

Fumiyoshi Yamashita

Department of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
FYFumiyoshi Yamashita
Fumiyoshi Yamashita
MHMitsuru Hashida
Mitsuru Hashida
Combinatorial chemistry and high-throughput screening have increased the possibility of finding new lead compounds at much shorter time periods than conventional medicinal chemistry. However, too much promising drug candidates often fail because of unsatisfactory ADME properties. In silico ADME studies are expected to reduce the risk of late-stage attrition of drug development and to optimize screening and testing by looking at only the promising compounds. To this end, many in silico approaches for predicting ADME properties of compounds from their chemical structure have been developed, ranging from data-based approaches such as quantitative structure-activity relationship (QSAR), similarity searches, and 3-dimensional QSAR, to structure-based methods such as ligand-protein docking and pharmacophore modelling. In addition, several methods of integrating ADME properties to predict pharmacokinetics at the organ or body level have been studied. In this article, we briefly summarize in silico ADME approaches.

24 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FYFumiyoshi Yamashita
Fumiyoshi Yamashita
YSYukako Sasa
Yukako Sasa
SYShuya Yoshida
Shuya Yoshida
AHAkihiro Hisaka
Akihiro Hisaka
YAYoshiyuki Asai
Yoshiyuki Asai
HSHiroshi Suzuki
Hiroshi Suzuki
Induction of cytochrome P450 3A4 (CYP3A4) expression is often implicated in clinically relevant drug-drug interactions (DDI), as metabolism catalyzed by this enzyme is the dominant route of elimination for many drugs. Although several DDI models have been proposed, none have comprehensively considered the effects of enzyme transcription/translation dynamics on induction-based DDI. Rifampicin is a well-known CYP3A4 inducer, and is commonly used as a positive control for evaluating the CYP3A4 induction potential of test compounds. Herein, we report the compilation of in vitro induction data for CYP3A4 by rifampicin in human hepatocytes, and the transcription/translation model developed for this enzyme using an extended least squares method that can account for inherent inter-individual variability. We also developed physiologically based pharmacokinetic (PBPK) models for the CYP3A4 inducer and CYP3A4 substrates. Finally, we demonstrated that rifampicin-induced DDI can be predicted with reasonable accuracy, and that a static model can be used to simulate DDI once the blood concentration of the inducer reaches a steady state following repeated dosing. This dynamic PBPK-based DDI model was implemented on a new multi-hierarchical physiology simulation platform named PhysioDesigner.

16 November 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
RORyosaku Ota
Ryosaku Ota
FYFumiyoshi Yamashita
Fumiyoshi Yamashita

1 April 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
CFChunlai Feng
Chunlai Feng
HZHaisheng Zhang
Haisheng Zhang
JCJiaming Chen
Jiaming Chen
SWSiqi Wang
Siqi Wang
YXYuanrong Xin
Yuanrong Xin
XXXiming Xu
Ximing Xu

23 January 2008 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
FYFumiyoshi Yamashita
Fumiyoshi Yamashita
HHHideto Hara
Hideto Hara
TITakayuki Ito
Takayuki Ito
MHMitsuru Hashida
Mitsuru Hashida

19 August 2003 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
MNMakiya Nishikawa
Makiya Nishikawa
TNTakayuki Nakano
Takayuki Nakano
TOTakayuki Okabe
Takayuki Okabe
NHNobuko Hamaguchi
Nobuko Hamaguchi
YYYasuomi Yamasaki
Yasuomi Yamasaki
MHMitsuru Hashida
Mitsuru Hashida